STOCK TITAN
  1. Home
  2. News
  3. MDT

Medtronic Plc - MDT STOCK NEWS

Welcome to our dedicated news page for Medtronic Plc (Ticker: MDT), a resource for investors and traders seeking the latest updates and insights on Medtronic Plc.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Medtronic Plc's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Medtronic Plc's position in the market.

News
Medtronic Named One of America's Most JUST Companies
Rhea-AI Summary
JUST Capital, in collaboration with CNBC, released its annual JUST 100 list, recognizing American corporate leadership on business issues prioritized by the public. Medtronic was named one of America's Most JUST Companies for the 2nd consecutive year, demonstrating commitment to serving workers, customers, communities, the environment, and shareholders. The JUST 100 companies outperform their peers financially and demonstrate better performance in areas such as paying a living wage, career development training, parental leave, water usage, CO2 emissions, renewable energy use, profit margin, return on equity, and dividend yield.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1%
Tags
none
-
News
Medtronic: Here Comes the Sun - 3 Things To Know About Our Solar Footprint
Rhea-AI Summary
Medtronic has been investing in renewable energy sources like solar, with a commitment to be net zero by 2045. The company's first solar farm opened in 2014 and they have since expanded their solar energy footprint globally, with the recent addition of a solar energy farm at their Mounds View, Minnesota campus. Medtronic used approximately 414,300 megawatt hours (MWh) of renewable electricity last year, accounting for more than 46% of their total electricity usage.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.02%
Tags
none
-
News
Medtronic LABS President Ruchika Singhal Named “Corporate Social Innovator of the Year” by Schwab Foundation
Rhea-AI Summary
Medtronic LABS president, Ruchika Singhal, was named the 2024 'Corporate Social Innovator of the Year' by the Schwab Foundation for Social Entrepreneurship. The independent nonprofit organization, supported by Medtronic, has impacted over 1.6 million patients, enrolled 237,000 people in healthcare programs, and improved over 100,000 lives through its data, technology, and partnerships to address health issues in underserved communities globally.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.01%
Tags
none
News
FDA approves Medtronic Percept™ RC neurostimulator with exclusive BrainSense™ technology
Rhea-AI Summary
Medtronic plc (MDT) announces FDA approval of Percept™ RC Deep Brain Stimulation (DBS) system, the latest innovation in the Percept™ family, offering personalized treatment for patients with movement disorders and epilepsy. The system features BrainSense™ technology, SenSight™ directional leads, and a rechargeable neurostimulator with at least 15 years of service life and rapid recharging capabilities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.36%
Tags
fda approval
-
News
Medtronic Diabetes announces world's first approval for MiniMed™ 780G System with Simplera Sync™ disposable, all-in-one sensor
Rhea-AI Summary
Medtronic plc (MDT) receives CE Mark approval for the MiniMed™ 780G system with Simplera Sync™ sensor, offering improved user experience and half the size of previous sensors. The system automatically adjusts glucose levels and features a Meal Detection™ feature to reduce post-meal hyperglycemia. The system is also compatible with the world's only 7-day infusion set and requires no fingersticks.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.36%
Tags
none
-
News
Medtronic receives CE Mark for its next generation Micra leadless pacing systems
Rhea-AI Summary
Medtronic plc (MDT) has received CE Mark for its Micra™ AV2 and Micra™ VR2, the next generation of its miniature, leadless pacemakers. The new pacemakers offer 40% more battery life, projecting a battery life of nearly 16 and 17 years, respectively. Additionally, they are the world's smallest pacemakers and the only leadless pacemakers with remote monitoring capabilities, providing significant benefits to patients. Medtronic's legacy in cardiac pacing includes several groundbreaking innovations, positioning the company as a leader in the industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
none
News
Hypertension Control Program Aims to Tackle Major Driver of Health Disparities for Black Americans
Rhea-AI Summary
Association of Black Cardiologists (ABC) announced the launch of its Hypertension Control Program, offering 50 member clinicians the opportunity to receive American Hypertension Specialist Certification. The program aims to improve cardiovascular health outcomes for Black patients, who are disproportionately impacted by hypertension. Medtronic is sponsoring the program and providing support for clinicians to receive certification.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
none
-
News
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
Rhea-AI Summary
Medtronic plc (NYSE:MDT) to participate in the 42nd annual J.P. Morgan healthcare conference. Geoff Martha, Chairman and CEO, will make a formal presentation and answer questions on January 8, 2024. A live webcast of the presentation and Q&A session will be available on the company's investor relations webpage.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
conferences
-
News
Medtronic Continues To Rank in the DJSI World Index for 2023
Rhea-AI Summary
Medtronic plc (MDT) continues to be included in the Dow Jones Sustainability World Index (DJSI) as one of the world's leading companies for sustainability, based on their strong environmental, social, and governance (ESG) management and performance. The company's FY2023 Sustainability Report highlights progress on ESG targets, including revenue from new products, patient access, inclusion, diversity, equity, responsible supply management, climate risk and resilience, and patient safety and product quality.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.98%
Tags
none
News
Medtronic creates history with FDA approval of its novel PulseSelect™ Pulsed Field Ablation System to treat atrial fibrillation
Rhea-AI Summary
Medtronic plc (NYSE: MDT) has received FDA approval for the PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation. The system is the first of its kind to receive FDA approval and boasts excellent safety, efficacy, and efficiency. The PulseSelect PFA system is designed to provide rapid, effective pulmonary vein isolation (PVI) and is supported by the PULSED AF study, showing a 0.7% safety event rate and clinical success rates of 80% in both paroxysmal and persistent AF patients. The system also includes differentiated safety features, built-in safety measures, and a small, maneuverable catheter, making it a significant advancement in AF ablation technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.87%
Tags
fda approval
Stock MDT logo
Medtronic Plc

NYSE:MDT

MDT Rankings

#109 Ranked by Market Cap
#3364 Ranked by Stock Gains
#1001 Ranked by Dividends

MDT Stock Data

106.40B
1.33B
0.11%
85.18%
0.94%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
US
Minneapolis

About MDT

Medtronic plc is an American medical device company. The companys operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Ireland due to its acquisition of Irish-based Covidien in 2015.